Tech Company Financing Transactions

Jenrin Discovery Funding Round

BioAdvance Ventures participated in a $500 thousand funding round for Jenrin Discovery. The round closed on 3/31/2005.

Transaction Overview

Company Name
Announced On
3/31/2005
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors

BioAdvance Ventures (Barbara Schilberg)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
285 Wilmington-West Chester Pike
Chadds Ford, PA 19317
USA
Phone
Undisclosed
Email Address
Overview
Jenrin Discovery, Inc. is a privately owned emerging pharmaceutical company focused on developing safer and more effective therapeutics for a variety of chronic diseases, including obesity, diabetes and autoimmune/inflammatory disorders.
Profile
Jenrin Discovery LinkedIn Company Profile
Social Media
Jenrin Discovery Company Twitter Account
Company News
Jenrin Discovery News
Facebook
Jenrin Discovery on Facebook
YouTube
Jenrin Discovery on YouTube

Management Team

Title
Name
Email & Social
Chief Scientific Officer
Robert Chorvat
  Robert Chorvat LinkedIn Profile  Robert Chorvat Twitter Account  Robert Chorvat News  Robert Chorvat on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2005: SupplyFrame venture capital transaction
Next: 3/31/2005: UltraCell venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary